Comprehensive Metaboproteomics of Burkitt’s and Diffuse Large B-Cell Lymphoma Cell Lines and Primary Tumor Tissues Reveals Distinct Differences in Pyruvate Content and MetabolismPhilipp Schwarzfischer, Peter J. Oefner, Wolfram Gronwald et al.|Journal of Proteome Research|2017Cited by 28
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphomaKarsten Kleo, Michael Hummel, Lora Dimitrova et al.|BMC Cancer|2019Cited by 11
Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissueClaudia Vollbrecht, Michael Hummel, Inga Hoffmann et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2022Cited by 10
Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer TissueCarolin Schmidt, Ramona Erber, Lora Dimitrova et al.|Journal of Molecular Diagnostics|2024Cited by 2
Additional file 3: of Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphomaKarsten Kleo, Michael Hummel, Lora Dimitrova et al.|Figshare|2019Cited by 0